Vanguard Portfolio Management
AGIO icon

Vanguard Portfolio Management’s Agios Pharmaceuticals AGIO Stock Holding History

Vanguard Portfolio Management’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$108M Buy
2,898,197
+287,162
+11% +$8.71M ﹤0.01% 1477
2026
Q1 		$88.3M Buy
+2,611,035
New +$74M ﹤0.01% 1481

Other funds holding AGIO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management's AGIO Position: Q2 2026 in Review

Vanguard Portfolio Management increased its Agios Pharmaceuticals (AGIO) stake by 11% in Q2 2026, buying an estimated $8.71M and bringing the position to 2,898,197 shares worth $108M. The position accounts for ﹤0.01% of the portfolio, ranked #1477.

Vanguard Portfolio Management first reported a position in AGIO in Q1 2026 and has held it in 2 quarters since. 236 funds tracked by Wall St. Rank hold AGIO as of Q2 2026.

  • Vanguard Portfolio Management held 2,898,197 shares of Agios Pharmaceuticals worth $108M as of Q2 2026.
  • Vanguard Portfolio Management bought 287,162 Agios Pharmaceuticals shares in Q2 2026, an estimated $8.71M.
  • Agios Pharmaceuticals made up ﹤0.01% of Vanguard Portfolio Management's portfolio in Q2 2026, its #1477 holding.
  • Vanguard Portfolio Management first reported a position in Agios Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
  • 236 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q2 2026.

Based on Vanguard Portfolio Management's 13F filing for Q2 2026, filed 13 Aug 2026.